HSPA5 and cancer: A bacterial cytotoxin SubAB has an unusual ability to specifically cleave GRP78 without affecting other proteins in the cell.12 Although its potential use in the treatment of cancer is unattainable because of systemic toxicity associated with promiscuous binding of B-subunit, a targeted delivery of the catalytic subunit A makes therapeutic approaches more feasible.